As of 2025-05-21, the Fair Value of Sunshine Biopharma Inc (SBFM) is -7.05 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.50 USD, the upside of Sunshine Biopharma Inc is -571.73%.
With the market price of 1.50 USD and our fair value calculation, Sunshine Biopharma Inc (SBFM) is not a good investment. Investing in SBFM stocks now will result in a potential loss of 571.73%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -2.78 | -12.44 | -26.74 | -4.51 | -5.13 | -10.32 |
| YoY growth | -67.71% | -346.70% | -115.05% | 83.15% | -13.94% | -92.05% |
| Market Cap (mil) | 5.44 |
| P/E | |
| Forward P/E |
| EPS | -1.41 |
| Avg earnings growth rate | -92.05% |
| TTM earnings | -5.13 |